keyword
https://read.qxmd.com/read/38672740/efficacy-of-digital-therapeutics-for-pulmonary-rehabilitation-a-multi-center-randomized-controlled-trial
#1
JOURNAL ARTICLE
Chul Kim, Hee-Eun Choi, Chin Kook Rhee, Jun Hyeong Song, Jae Ha Lee
BACKGROUND: This study aimed to investigate the efficacy and safety of digital therapeutics (DTx), EASYBREATH, for pulmonary rehabilitation (PR) in patients with chronic respiratory diseases (CRDs). MATERIALS AND METHODS: This prospective randomized controlled trial was conducted at multiple centers. Participants were randomly allocated 1:1 to the DTx group (DTxG), provided with DTx using EASYBREATH. The DTxG underwent an 8-week PR program with evaluations conducted at baseline, four weeks, and eight weeks...
April 3, 2024: Life
https://read.qxmd.com/read/38663359/longterm-erythromycin-treatment-alters-the-airway-and-gut-microbiota%C3%AF-data-from-copd-patients-and-mice-with-emphysema
#2
JOURNAL ARTICLE
Guangsheng Pei, Liyan Guo, Siqiao Liang, Fugang Chen, Nan Ma, Jing Bai, Jingmin Deng, Meihua Li, Chunhai Qin, Tao Feng, Zhiyi He
INTRODUCTION: Although long-term macrolide antibiotics could reduce the recurrent exacerbation of chronic obstructive pulmonary disease (COPD), the side effect of bacterial resistance and the impact on the microbiota remain concerning. We investigated the influence of long-term erythromycin treatment on the airway and gut microbiota in mice with emphysema and patients with COPD. METHODS: We conducted 16S rRNA gene sequencing to explore the effect of erythromycin treatment on the lung and gut microbiota in mice with emphysema...
April 25, 2024: Respiration; International Review of Thoracic Diseases
https://read.qxmd.com/read/38652265/umeclidinium-plus-vilanterol-versus-fluticasone-propionate-plus-salmeterol-for-chronic-obstructive-pulmonary-disease-a-meta-analysis-of-randomized-controlled-trials
#3
JOURNAL ARTICLE
Chunjuan Zhai, Fen Wang, Ruie Xu, Xia Sun, Wenbin Ma, Li Wang
PURPOSE: Umeclidinium plus vilanterol (UMEC/VI) is an inhaled long-acting muscarinic antagonist/long-acting beta2-agonist (LAMA/LABA), recently approved as once-daily maintenance therapy for chronic obstructive pulmonary disease (COPD). This meta-analysis aims to assess the efficacy and safety of UMEC/VI compared with fluticasone propionate plus salmeterol (FP/SAL). METHODS: A systematic search was conducted by a trained medical research librarian across MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and Chinese Biomedical Literature Database (CBM) for randomized controlled trials comparing UMEC/VI with FP/SAL in COPD patients...
April 23, 2024: Postgraduate Medical Journal
https://read.qxmd.com/read/38618447/effectiveness-of-telemedicine-interventions-in-chronic-obstructive-pulmonary-disease-copd-management-a-randomized-controlled-trial-comparing-yoga-therapy-and-pulmonary-rehabilitation-over-three-months
#4
JOURNAL ARTICLE
Ruchi Dua, Saloni Malik, Ajeet S Bhadoria, Osama Neyaz, Ajay S Krishnan, Chinmay Pandya
Background Pulmonary rehabilitation (PR) is an integral part of non-pharmacological therapy in chronic obstructive pulmonary disease (COPD). Yoga therapy (YT) has been shown to be beneficial in COPD, but the lack of large well-designed trials and standardized modules restricts its acceptability. This randomized control trial compares these two modalities in COPD patients via supervised tele-intervention. Objectives The primary objective of the study is to compare a 45-minute, five-days-per-week series of tele-YT (T-YT) with tele-PR (T-PR) for three months in terms of exercise capacity (6-Minute Walk Distance (6MWD)) in COPD patients...
March 2024: Curēus
https://read.qxmd.com/read/38613061/improvement-of-lung-function-by-micronutrient-supplementation-in-patients-with-copd-a-systematic-review-and-meta-analysis
#5
REVIEW
Mingxin Li, Liangjie Zhao, Chenchen Hu, Yue Li, Yang Yang, Xiaoqi Zhang, Quanguo Li, Aiguo Ma, Jing Cai
BACKGROUND: A healthy, well-balanced diet plays an essential role in respiratory diseases. Since micronutrient deficiency is relatively common in patients with chronic obstructive pulmonary disease (COPD), micronutrient supplementation might have the beneficial health effects in those patients. This systematic review and meta-analysis aimed to demonstrate the impact of micronutrient supplementation on the lung function of patients with COPD. METHODS: The PubMed, Cochrane Library, and Web of Science databases were searched from their corresponding creation until February 2024...
April 1, 2024: Nutrients
https://read.qxmd.com/read/38609766/-non-invasive-ventilation-in-acute-respiratory-failure-of-oncology-hematology-patients-what-are-its-current-benefits-and-limitations
#6
REVIEW
J Mayaux, M Decavele, M Dres, M Lecronier, A Demoule
Acute respiratory failure (ARF) is a leading cause, along with sepsis, of admission to the intensive care unit (ICU) of patients with active cancer. Presenting variable clinical severity, ARF in onco-hematological patients has differing etiologies, primarily represented by possibly opportunistic acute infectious pneumonia (de novo hypoxemic ARF), and decompensation in chronic cardiac or respiratory diseases (e.g., acute pulmonary edema or exacerbated chronic obstructive pulmonary disease). In these patients, orotracheal intubation is associated with a doubled risk of in-hospital mortality...
April 11, 2024: Revue des Maladies Respiratoires
https://read.qxmd.com/read/38606705/-not-available
#7
JOURNAL ARTICLE
Pradeesh Sivapalan, Josefin Eklöf, Barbara Bonnesen, Louise Tønnesen, Torgny Wilcke, Jens-Ulrik Stæhr Jensen
This review highlights key aspects of treating chronic obstructive pulmonary disease (COPD) exacerbation, focusing on the optimisation of systemic corticosteroid and antibiotic use through personalised treatment using biomarkers. Eosinophil-guided therapy reduces corticosteroid usage which might reduce side effects, while procalcitonin-guided therapy contributes to reduced antibiotic consumption. These approaches, documented through well-conducted randomized controlled trials, suggest the possibility of enhancing COPD exacerbation management, reducing potential side effects, and addressing concerns related to antibiotic resistance...
April 1, 2024: Ugeskrift for Laeger
https://read.qxmd.com/read/38600554/effectiveness-of-immunoglobulin-replacement-therapy-in-preventing-infections-in-patients-with-chronic-obstructive-pulmonary-disease-a-systematic-review
#8
JOURNAL ARTICLE
Justin J Y Kim, Liz Dennett, Maria B Ospina, Anne Hicks, Harissios Vliagoftis, Adil Adatia
PURPOSE: Immunoglobulin replacement therapy is a standard treatment for patients with antibody production deficiencies, which is of interest in patients with chronic obstructive pulmonary disease (COPD). This systematic review, registered with PROSPERO (CRD42021281118), assessed the current literature regarding immunoglobulin replacement therapy on COPD clinical outcomes in patients with low immunoglobulin G (IgG) serum concentrations. METHODS: Literature searches conducted from inception to August 23, 2021, in databases including MEDLINE, EMBASE, and CINAHL...
April 10, 2024: Allergy, Asthma, and Clinical Immunology
https://read.qxmd.com/read/38599052/treatment-with-systemic-corticosteroid-versus-placebo-for-exacerbations-of-copd-a-systematic-review-and-meta-analysis
#9
JOURNAL ARTICLE
Akira Koarai, Mitsuhiro Yamada, Tomohiro Ichikawa, Naoya Fujino, Hisatoshi Sugiura
BACKGROUND: For the treatment of COPD exacerbations, systemic corticosteroids are recommended in addition to short-acting bronchodilators. Although there have been several systemic reviews, many of the included studies were conducted before 2007 and a re-evaluation has not been performed since 2014. Therefore, we conducted a systematic review and meta-analysis to evaluate the efficacy and safety profile of systemic corticosteroids in patients with COPD during exacerbations. METHODS: We searched relevant randomized control trials (RCTs) and analyzed the treatment failure, relapse, lung function, improvement in PaO2 and PaCO2 , dyspnea, quality of life (QOL), length of stay in hospital and adverse events including hyperglycemia and mortality as the outcomes of interest...
May 2024: Respiratory Investigation
https://read.qxmd.com/read/38582877/a-placebo-controlled-crossover-trial-to-investigate-the-efficacy-of-tiotropium-bromide-or-placebo-added-to-usual-care-in-stable-symptomatic-post-hematopoietic-stem-cell-transplantation-hsct-bronchiolitis-obliterans-syndrome-bos
#10
RANDOMIZED CONTROLLED TRIAL
Naeemeh Dini, Amin Pastaki Khoshbin, Rasoul Aliannejad, Hooman Bakhshandeh, Katayoun Najafizadeh, Mahshid Mehdizadeh, Shahideh Amini
BACKGROUND: Despite the fundamental progress in hematopoietic stem cell transplant, this treatment is also associated with complications. Graft-versus-host disease is a possible complication of HSCT. Bronchiolitis obliterans syndrome (BOS) is the pulmonary form of this syndrome. Due to the high morbidity and mortality rate of BOS, various studies have been conducted in the field of drug therapy for this syndrome, although no standard treatment has yet been proposed. According to the hypotheses about the similarities between BOS and chronic obstructive pulmonary disease, the idea of using tiotropium bromide as a bronchodilator has been proposed...
April 6, 2024: Trials
https://read.qxmd.com/read/38576558/effect-of-respiratory-muscle-training-in-patients-with-stable-chronic-obstructive-pulmonary-disease-a-systematic-review-and-meta-analysis
#11
JOURNAL ARTICLE
Zhongjie Huang, Zhibin Li, Meihao Yan, Jianming Zheng, Wencheng Huang, Liyue Hong, Qiuxiang Lu, Limin Liu, Xincheng Huang, Hongtao Fan, Weiping Su, Xiaoping Huang, Xiaoyan Wu, Zhixiong Guo, Caiting Qiu, Zhaodi Zhao, Yuancheng Hong
OBJECTIVES: Chronic obstructive pulmonary disease (COPD) is a prevalent respiratory disorder characterized by progressive airflow limitation. This meta-analysis aims to evaluate the effectiveness of respiratory muscle training (RMT) on key pulmonary function parameters, inspiratory muscle strength and quality of life in patients with stable COPD. METHODS: A comprehensive search was conducted in the databases including PubMed, Cochrane, Web of Science, Embase, and ClinicalTrials...
April 15, 2024: Heliyon
https://read.qxmd.com/read/38568930/high-flow-nasal-cannula-oxygen-therapy-versus-non-invasive-ventilation-in-patients-at-very-high-risk-for-extubating-failure-a-systematic-review-of-randomized-controlled-trials
#12
JOURNAL ARTICLE
Ziyad F Al Nufaiei, Raid M Al Zhranei
BACKGROUND: Mechanical ventilation is commonly used for managing respiratory failure in chronic obstructive pulmonary disease (COPD) patients, but weaning patients off ventilator support can be challenging and associated with complications. While many patients respond well to Non-invasive ventilation (NIV), a significant proportion may not respond as favourably. We aimed to assess whether high-flow nasal cannula (HFNC) is equally effective as NIV in reducing extubation failure among previously intubated COPD patients...
2024: PloS One
https://read.qxmd.com/read/38566673/post-tracheostomy-steroid-nebulization-a-retrospective-analysis-on-postoperative-complications
#13
JOURNAL ARTICLE
Sanjay Kumar, Kashiroygoud Biradar, Arun Patra
The primary objective of this research was to meticulously evaluate the therapeutic potential of steroid nebulization, administered over a 2-week period post-tracheostomy, in attenuating postoperative complications with a concentrated emphasis on tracheal stenosis. The study spanned three years, commencing in 2019 and concluding in 2022, examining a patient cohort of 400 individuals. Utilizing a retrospective cohort methodology, the participants were systematically stratified into two cohorts: those subjected to steroid nebulization ( n  = 200) and a control group ( n  = 200)...
April 2024: Indian Journal of Otolaryngology and Head and Neck Surgery
https://read.qxmd.com/read/38566419/self-management-intervention-for-patients-following-hospitalization-for-acute-exacerbation-of-chronic-obstructive-pulmonary-disease-aecopd-a-pilot-randomized-controlled-trial
#14
RANDOMIZED CONTROLLED TRIAL
Susan Barnason, Jennifer N Miller, Sue Schuelke, Jessica J Miller, Kevin Kupzyk
The purpose of this study was to evaluate the handoff guidance (HG) self-management intervention for multimorbid chronic obstructive pulmonary disease (COPD) patients following hospitalization for acute exacerbation of COPD (AECOPD) using HG self-management intervention compared to a control group on COPD self-management outcomes (self-care, self-efficacy, health engagement) and assess feasibility, acceptability, and healthcare utilization. A randomized pilot study used a 2-group with repeated measures design...
June 2024: Nursing & Health Sciences
https://read.qxmd.com/read/38565305/direct-health-care-costs-associated-with-a-multicomponent-copd-exacerbation-intervention
#15
JOURNAL ARTICLE
Louise Rose, Laura Istanboulian, Shaghayegh Rezaie, Ian Fraser
BACKGROUND: Health care costs attributed to COPD have been estimated at $4.7 trillion globally in the next 30 years. With the global burden of COPD rising, identification of interventions that might lead to health care cost savings is an imperative. Although many studies report the effect of COPD self-management interventions on subject outcomes and health care utilization, few data describe their effect on health care costs. METHODS: Using data linkage and established case-costing methods with provincial Canadian health databases, we established public health care costs (acute and community) for 12 months following randomization for the 462 participants enrolled in our randomized controlled trial of the Program of Integrated Care for Patients with COPD and Multiple Comorbidities...
April 2, 2024: Respiratory Care
https://read.qxmd.com/read/38560416/clinical-burden-of-chronic-obstructive-pulmonary-disease-in-patients-with-suboptimal-peak-inspiratory-flow
#16
JOURNAL ARTICLE
Jill A Ohar, Donald A Mahler, Gabrielle N Davis, David A Lombardi, Edmund J Moran, Glenn D Crater
INTRODUCTION: Many patients with chronic obstructive pulmonary disease (COPD) may derive inadequate benefit from dry powder inhalers (DPIs) because of suboptimal peak inspiratory flow (sPIF). OBJECTIVES: To assess the clinical burden of COPD by characterizing the clinical characteristics of participants with sPIF against medium-low resistance DPIs versus those with optimal PIF (oPIF) from two phase 3 clinical trials. METHODS: Baseline data were collected from two randomized, controlled, phase 3 trials (NCT03095456; NCT02518139) in participants with moderate-to-severe COPD...
2024: Canadian Respiratory Journal: Journal of the Canadian Thoracic Society
https://read.qxmd.com/read/38558439/home-based-management-on-hospital-re-admission-rates-in-copd-patients-a-systematic-review
#17
REVIEW
Rita Corcoran, Zena Moore, Pinar Avsar, Bridget Murray
AIM: To determine the impact of home-based management on hospital re-admission rates in patients with chronic obstructive pulmonary disease (COPD). DESIGN: Systematic review methodology was utilized, combining meta-analysis, where appropriate, or a narrative analysis of the data from included studies. DATA SOURCES: Electronic databases CINAHL, MEDLINE, PubMed, Embase and SAGE journals for primary papers, 2015 to 2021, were searched between December 2020 and March 2021, followed by hand-searching key journals, and reference lists of retrieved papers...
April 1, 2024: Journal of Advanced Nursing
https://read.qxmd.com/read/38541103/a-chronic-obstructive-pulmonary-disease-self-management-intervention-for-improving-patient-reported-outcomes-in-primary-care-in-greece
#18
RANDOMIZED CONTROLLED TRIAL
Filothei Tsaousi, Izolde Bouloukaki, Antonios Christodoulakis, Despo Ierodiakonou, Nikos Tzanakis, Ioanna Tsiligianni
Background and Objectives : Self-management programs are essential for increasing COPD patient participation and autonomy in making appropriate decisions about their chronic condition. The present study aimed to assess the impact of COPD self-management interventions on quality of life, functional status, patient education, depression, and anxiety in primary care. Materials and Methods : We conducted a randomized controlled trial recruiting patients with COPD (GOLD A and B) from four primary care centers in Crete, Greece, with one intervention group ( n = 40) receiving self-management educational support and one control group ( n = 80) receiving usual care...
February 23, 2024: Medicina
https://read.qxmd.com/read/38536775/inflammatory-biomarker-based-clinical-practice-in-patients-with-pneumonia-a-systematic-review-of-randomized-controlled-trials
#19
JOURNAL ARTICLE
Dimitrios Dimitropoulos, Michalis Karmpadakis, Themistoklis Paraskevas, Christos Michailides, Maria Lagadinou, Christina Platanaki, Charalampos Pierrakos, Dimitrios Velissaris
UNLABELLED: Objectives: Biomarker-based clinical practice is currently gaining ground and increasingly affects decision making. A variety of biomarkers have been studied through the years and some of them have already an established role in modern medicine, such as procalcitonin (PCT) which has been proposed to reduce antibiotic exposure. We purposed to systematically review all biomarkers examined for guiding the clinical practice in patients with pneumonia. METHODS: A systematic review on PubMed was performed on April 2023 by two independent researchers using the PRISMA guidelines...
March 27, 2024: Romanian Journal of Internal Medicine
https://read.qxmd.com/read/38523907/efficacy-and-safety-of-a-music-therapy-facilitated-pulmonary-telerehabilitation-program-in-copd-patients-the-copdmelody-study-protocol
#20
JOURNAL ARTICLE
Minghui Shi, Lulu Yang, Shiwei Qumu, Jieping Lei, Ke Huang, Ruoxi He, Hongtao Niu, Fen Dong, Siyuan Wang, Jiaze He, Ting Yang
Despite considerable evidence for the benefit in chronic obstructive pulmonary disease (COPD), the implementation of pulmonary rehabilitation (PR) is insufficient. However, music therapy may help address this gap due to its unique benefits. Therefore, we aimed to develop a music-therapy facilitated pulmonary telerehabilitation program based on rhythm-guided walking, singing, and objective telemonitoring. A supervised, parallel-group, single-blinded, randomized controlled clinical trial will be conducted, including 75 patients with COPD anticipated to be randomized in a 1:1:1 ratio into three groups...
2024: Frontiers in Medicine
keyword
keyword
76972
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.